Evidence map›Paper›PMID 25893720›Full record

ArticleEuropean journal of nutrition2016

Probiotic Lactobacillus casei Zhang reduces pro-inflammatory cytokine production and hepatic inflammation in a rat model of acute liver failure.

Yuzhen Wang, Jiming Xie, Yunxu Li, Shichao Dong, Huan Liu, Junna Chen, Yan Wang, Shimin Zhao, Yong Zhang, Heping Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nutrition, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it, 83 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Review
  7. Article
  8. Formulation-dependent kinetics ofMicrobiology spectrum · 2026
    Article
  9. Review
  10. Article
  11. Foods (Basel, Switzerland) · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. International journal of molecular sciences · 2025
    Article
  16. Review
  17. Review
  18. Review
  19. Regulation of Gut Microflora byInternational journal of molecular sciences · 2023
    Article
  20. Mucin Binding Protein ofNutrients · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Yuzhen WangDepartment of Pharmaceutical Engineering, College of Life Science, Inner Mongolia Agricultural University, No. 306 Zhaowuda Road, Saihan district, Hohhot, 010018, People's Republic of China. wangyuzhen817@126.com.
Jiming XieClinical Laboratory, Inner Mongolia People's Hospital, Hohhot, People's Republic of China.
Yunxu LiDepartment of Pharmaceutical Engineering, College of Life Science, Inner Mongolia Agricultural University, No. 306 Zhaowuda Road, Saihan district, Hohhot, 010018, People's Republic of China.
Shichao DongDepartment of Pharmaceutical Engineering, College of Life Science, Inner Mongolia Agricultural University, No. 306 Zhaowuda Road, Saihan district, Hohhot, 010018, People's Republic of China.
Huan LiuDepartment of Pharmaceutical Engineering, College of Life Science, Inner Mongolia Agricultural University, No. 306 Zhaowuda Road, Saihan district, Hohhot, 010018, People's Republic of China.
Junna ChenDepartment of Pharmaceutical Engineering, College of Life Science, Inner Mongolia Agricultural University, No. 306 Zhaowuda Road, Saihan district, Hohhot, 010018, People's Republic of China.
Yan WangDepartment of Pharmaceutical Engineering, College of Life Science, Inner Mongolia Agricultural University, No. 306 Zhaowuda Road, Saihan district, Hohhot, 010018, People's Republic of China.
Shimin ZhaoDepartment of Pharmaceutical Engineering, College of Life Science, Inner Mongolia Agricultural University, No. 306 Zhaowuda Road, Saihan district, Hohhot, 010018, People's Republic of China.
Yong ZhangKey Laboratory of Dairy Biotechnology and Bioengineering, Educational Ministry of China, College of Food Science and Engineering, Inner Mongolia Agricultural University, Hohhot, People's Republic of China.
Heping ZhangKey Laboratory of Dairy Biotechnology and Bioengineering, Educational Ministry of China, College of Food Science and Engineering, Inner Mongolia Agricultural University, Hohhot, People's Republic of China.
Inner Mongolia Agricultural University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeIn this study, we sought to find the effects and mechanisms of probiotic Lactobacillus casei Zhang (L. casei Zhang) on the pro-inflammatory cytokine production and hepatic inflammatory response in a rat model of acute liver failure induced by lipopolysaccharide (LPS) and d-galactosamine (GalN).

methodsMale Wistar rats were orally administrated with or without L. casei Zhang for 30 days prior to challenge with LPS and GalN. Dexamethasone administrated group serving as a positive anti-inflammation control. Serum, intestinal and liver samples were collected 8 h after LPS/GalN challenge for histological, molecular and biochemical analysis.

resultsLPS/GalN challenge alone resulted in significantly increased production of endotoxin, tumor necrosis factor-α (TNF-α), interleukin-1 beta (IL-1β) and nitric oxide as compared to the normal control rats. Pretreatment with L. casei Zhang not only reduced these changes, but also attenuated hepatic inflammation as shown by improved histological assessment, decreased myeloperoxidase activity and reduced expression of IL-1β and inducible nitric oxide synthase in the liver. L. casei Zhang supplementation significantly inhibited LPS/GalN-triggered phosphorylation of ERK, JNK and p-38 MAPK, but increased the expression of TLR2, TLR9 and PPAR-γ. Moreover, L. casei Zhang treatment prevented intestinal injury and modulated the intestinal ecology by increasing the fecal Lactobacillus and Bifidobacterium levels.

conclusionsProbiotic L. casei Zhang reduces LPS/GalN-induced pro-inflammatory cytokine and hepatic inflammation through modulating the TLR-MAPK-PPAR-γ signaling pathways and intestinal microbiota.

Indexed as

Lacticaseibacillus caseiAcute DiseaseAnimalsAnti-Inflammatory AgentsBifidobacteriumCytokinesDexamethasoneDisease Models, AnimalExtracellular Signal-Regulated MAP KinasesGalactosamineGastrointestinal MicrobiomeJNK Mitogen-Activated Protein KinasesLipopolysaccharidesLiverLiver DiseasesMaleAnti-Inflammatory AgentsCytokinesDexamethasoneExtracellular Signal-Regulated MAP KinasesGalactosamineJNK Mitogen-Activated Protein KinasesLipopolysaccharidesNitric OxideNitric Oxide Synthase Type IINos2 protein, ratPPAR gammaTlr2 protein, ratTlr9 protein, ratToll-Like Receptor 2Toll-Like Receptor 9InflammationLactobacillus caseiMicrobiotaPPAR-γTNF-α

Identifiers

PMID25893720
OpenAlexW2024956244

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.